1092
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
PEDIATRIC PNEUMONIA: CLINICAL FEATURES, DIAGNOSIS, MANAGEMENT,
AND GLOBAL HEALTH IMPACT
Murtazayeva Zilola Faxriddinovna
Department of Fundamental Medical Sciences of the Asian International University.
Bukhara,Uzbekistan
https://doi.org/10.5281/zenodo.15242522
Abstract.
Pneumonia is a leading cause of morbidity and mortality in children under five,
particularly in low- and middle-income countries. Despite advances in immunization and
healthcare access, the disease continues to pose a serious burden due to delayed diagnosis,
inappropriate antibiotic use, and rising antimicrobial resistance. This article provides a
comprehensive review of the etiology, pathophysiology, clinical presentation, diagnostic
modalities, treatment strategies, complications, and global initiatives aimed at reducing the
impact of pediatric pneumonia.
Keywords
: Pediatric pneumonia, respiratory infection, antibiotic therapy, WHO, child
mortality, clinical management.
ПНЕВМОНИЯ У ДЕТЕЙ: КЛИНИЧЕСКИЕ ОСОБЕННОСТИ, ДИАГНОСТИКА,
ЛЕЧЕНИЕ И ГЛОБАЛЬНОЕ ВОЗДЕЙСТВИЕ НА ЗДРАВООХРАНЕНИЕ
Аннотация.
Пневмония является основной причиной заболеваемости и
смертности у детей в возрасте до пяти лет, особенно в странах с низким и средним
уровнем дохода. Несмотря на достижения в области иммунизации и доступа к
здравоохранению, болезнь продолжает представлять серьезную проблему из-за поздней
диагностики, ненадлежащего использования антибиотиков и растущей устойчивости к
противомикробным препаратам. В этой статье представлен всесторонний обзор
этиологии, патофизиологии, клинической картины, диагностических методов,
стратегий лечения, осложнений и глобальных инициатив, направленных на снижение
воздействия пневмонии у детей.
Ключевые
слова:
пневмония
у
детей,
респираторная
инфекция,
антибиотикотерапия, ВОЗ, детская смертность, клиническое ведение.
Introduction
Pneumonia is defined as an acute lower respiratory tract infection affecting the alveoli
and surrounding tissues. It remains one of the deadliest infectious diseases among children under
the age of five. According to the World Health Organization (2023), pneumonia kills over
740,000 children annually
, which accounts for
approximately 13% of all under-five deaths
worldwide
.
1093
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
Despite being preventable and treatable, pediatric pneumonia remains a neglected disease
in many regions due to poor access to healthcare, lack of vaccination, and social determinants
such as malnutrition and indoor air pollution. An integrated approach involving clinical
vigilance, public health interventions, and caregiver education is essential.
Etiology and Risk Factors
The etiology of pneumonia varies by age, season, region, and comorbid conditions. It can
be classified into three main types based on the causative agent:
Bacterial Pneumonia
Streptococcus pneumoniae
is the most common cause worldwide.
Haemophilus influenzae type b (Hib)
and
Staphylococcus aureus
are also significant.
In neonates:
Group B Streptococcus
,
E. coli
,
Listeria monocytogenes
are typical
pathogens.
Viral Pneumonia
More frequent in children <5 years.
Common viruses include
Respiratory Syncytial Virus (RSV)
,
Influenza A and B
,
Adenovirus
,
Parainfluenza
,
Human metapneumovirus
.
Atypical Pneumonia
Caused by
Mycoplasma pneumoniae
,
Chlamydophila pneumoniae
, and
Legionella
pneumophila
.
More common in school-aged children and adolescents.
Risk Factors
Malnutrition
Premature birth and low birth weight
Lack of exclusive breastfeeding
Air pollution and passive smoking
Incomplete immunization
HIV infection and other immunosuppressive conditions
Pathophysiology
Pneumonia develops when infectious agents bypass the host’s upper airway defenses,
reach the lower respiratory tract, and trigger an inflammatory response. The alveoli fill with pus
and fluid, impeding normal gas exchange and causing symptoms such as hypoxia and respiratory
distress. The immune response leads to local inflammation, capillary leakage, and sometimes
systemic complications.
Clinical Features
General Symptoms
1094
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
Fever
Cough (productive or dry)
Dyspnea
Tachypnea
Lethargy or irritability
Feeding difficulties (especially in infants)
Physical Examination Findings
Chest indrawing
Nasal flaring
Grunting
Cyanosis (in severe cases)
Crackles, decreased breath sounds, dullness to percussion on auscultation
Age-Specific Presentations
Infants (<2 months)
: Apnea, poor feeding, low-grade fever, subtle signs
Toddlers and preschoolers
: High fever, rapid breathing, productive cough
School-aged children
: More likely to present with atypical pneumonia signs (headache,
sore throat, wheezing)
Diagnostic Approaches
Clinical Criteria (WHO Guidelines)
Tachypnea
based on age
Chest indrawing
Inability to drink or breastfeed
Convulsions or altered consciousness
(signs of severe pneumonia)
Radiographic Assessment
Chest X-ray is used to confirm diagnosis, assess the extent, and detect complications
(e.g., pleural effusion, empyema).
Laboratory Investigations
Complete blood count (CBC)
: Leukocytosis or leukopenia
C-reactive protein (CRP), Procalcitonin
: Help differentiate bacterial vs. viral
infections
Blood cultures
in hospitalized cases
Pulse oximetry
: Routine to detect hypoxemia
Point-of-care ultrasound is increasingly used for bedside pneumonia diagnosis.
Management and Treatment
1095
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
General Principles
Early initiation of empiric antibiotic therapy
Supportive care: oxygen, fluids, fever management
Nutritional support, especially in malnourished children
Antibiotic Therapy
First-line for outpatient care
: Oral
amoxicillin
Hospitalized patients
: IV
ampicillin
or
ceftriaxone
, sometimes combined with
gentamicin
Atypical pathogens
: Macrolides (azithromycin, erythromycin)
Severe Pneumonia Management
Admission to hospital
Oxygen therapy for SpO₂ <92%
Frequent monitoring of respiratory status
Management of complications (e.g., drainage of pleural effusion)
Adjunctive Therapies
Nebulized bronchodilators (if wheezing present)
Antipyretics for fever
Zinc supplementation (especially in malnourished children)
Complications
If left untreated or in cases of delayed diagnosis, pneumonia can lead to:
Pleural effusion
Empyema
Lung abscess
Sepsis
Respiratory failure
Bronchiectasis
(chronic damage)
Early diagnosis and appropriate treatment reduce the incidence of complications
significantly.
Prevention Strategies
Routine immunization
:
Pneumococcal conjugate vaccine (PCV13)
Hib vaccine
Influenza vaccine
Measles vaccine
(reduces post-measles pneumonia risk)
Exclusive breastfeeding
(first 6 months)
1096
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
Adequate nutrition
and vitamin A supplementation
Reducing indoor air pollution
(clean cooking fuels, improved ventilation)
Public health education
for parents
Global Health Initiatives
Several organizations are working to reduce pneumonia-related deaths:
Integrated Management of Childhood Illness (IMCI)
– WHO and UNICEF strategy to
improve child health
GAVI, the Vaccine Alliance
– Expanding access to essential vaccines
Every Breath Counts Coalition
– Multi-sectoral effort to reduce childhood pneumonia
deaths by 70% by 2030
Conclusion
Pediatric pneumonia is a preventable and treatable illness that continues to claim
hundreds of thousands of lives annually. A multifaceted approach including vaccination, early
clinical recognition, appropriate antibiotic use, supportive care, and strong public health
infrastructure is necessary to reduce its burden. Pediatricians, primary care providers, and global
health policymakers must collaborate to implement cost-effective and sustainable interventions
for the prevention and management of pneumonia in children.
REFERENCES
1.
World
Health
Organization.
(2023).
Pneumonia
.
Retrieved
from
https://www.who.int/news-room/fact-sheets/detail/pneumonia
2.
UNICEF. (2023).
Pneumonia: The forgotten killer of children
. Retrieved from
https://www.unicef.org/pneumonia
3.
Rudan, I., Boschi-Pinto, C., Biloglav, Z., Mulholland, K., & Campbell, H. (2008).
Epidemiology and etiology of childhood pneumonia.
Bulletin of the World Health
Organization
, 86(5), 408–416. https://doi.org/10.2471/BLT.07.048769
4.
Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M., & Thomson, A.
(2011). British Thoracic Society guidelines for the management of community-acquired
pneumonia
in
children.
Thorax
,
66(Suppl
2),
ii1–ii23.
https://doi.org/10.1136/thx.2010.136119
5.
Jain, S., Williams, D. J., Arnold, S. R., Ampofo, K., Bramley, A. M., Reed, C., ... &
Team, C. I. (2015). Community-acquired pneumonia requiring hospitalization among US
children.
New
England
Journal
of
Medicine
,
372(9),
835–845.
https://doi.org/10.1056/NEJMoa1405870
1097
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
6.
Zar, H. J., & Ferkol, T. W. (2014). The global burden of respiratory disease–impact on
child health.
Pediatric Pulmonology
, 49(5), 430–434. https://doi.org/10.1002/ppul.23030
7.
McIntosh, K. (2002). Community-acquired pneumonia in children.
New England Journal
of Medicine
, 346(6), 429–437. https://doi.org/10.1056/NEJMra011994
8.
Ginsburg, A. S., & Klugman, K. P. (2010). Vaccination to reduce antimicrobial
resistance.
The
Lancet
Global
Health
,
375(9729),
1348–1350.
https://doi.org/10.1016/S0140-6736(10)61442-6
9.
Don, M., Valent, F., Korppi, M., Canciani, M. (2010). Differentiation of bacterial and
viral community-acquired pneumonia in children.
Pediatric International
, 52(7), 895–
https://doi.org/10.1111/j.1442-200X.2010.03155.x
10.
Murtazayeva, Z. F. (2024). THE ART OF CLINICAL CASE ANALYSIS IN
PEDIATRICS: A GUIDE FOR MEDICAL PROFESSIONALS.
European Journal of
Modern Medicine and Practice
,
4
(11), 443-447.
11.
Murtazayeva, Z. F. (2024). Nourishing Newborns: Feeding Strategies to Minimize
Allergy Risk in Preterm Infants.
American Journal of Bioscience and Clinical Integrity
,
1
(10), 64-71.
12.
Мухамедова, Ш. Т., & Муртазаева, З. Ф. (2024). Аллергические Заболевания У
Недоношенных Новорожденных И Их Связь С Типом Питания.
Research Journal of
Trauma and Disability Studies
,
3
(6), 43-47.
13.
Faxriddinovna, M. Z. (2025). YURAK ORTTIRILGAN NUQSONLARI: SABABLARI,
TASHXISI VA DAVOLASH USULLARI.
Журнал научных исследований и их
решений
,
3
(02), 80-82.
14.
Faxriddinovna, M. Z., Husnora, B., Xushvaqt, M., & Sevinch, R. (2025). CHALA TUG
‘ILGAN CHAQALOQLAR: MUAMMOLAR, PARVARISH VA ZAMONAVIY
DAVOLASH USULLARI.
Научный информационный бюллетень
,
6
(1), 261-263.
15.
Murtazayeva, Z. (2025). ALLERGY IN PRETERM INFANTS: PATHOPHYSIOLOGY,
CLINICAL MANIFESTATIONS, AND MANAGEMENT STRATEGIES.
Modern
Science and Research
,
4
(2), 742-748.
16.
Халимова, Ю. С. (2021). MORPHOFUNCTIONAL ASPECTS OF THE HUMAN
BODY IN THE ABUSE OF ENERGY DRINKS.
Новый день в медицине
,
5
(37), 208-
210.
17.
Халимова, Ю. С. (2022). МОРФОФУНКЦИОНАЛЬНЫЕ ОСОБЕННОСТИ
ЯИЧНИКОВ
КРЫС
ПРИ
ВОЗДЕЙСТВИИ
КОФЕИН
СОДЕРЖАЩИХ
НАПИТОК.
Gospodarka i Innowacje.
,
23
, 368-374.
1098
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
18.
Salokhiddinovna, X. Y. (2023). INFLUENCE OF EXTERNAL FACTORS ON THE
MALE
REPRODUCTIVE
SYSTEM.
EUROPEAN
JOURNAL
OF
MODERN
MEDICINE AND PRACTICE
,
3
(10), 6-13.
19.
Халимова, Ю. С., & Шокиров, Б. С. (2022). МОРФОФУНКЦИОНАЛЬНЫЕ
ООБЕННОСТИ
ВНУТРЕННИХ
ОРГАНОВ
ПРИ
ХРОНИЧЕСКОМ
АЛКОГОЛИЗМЕ.
Scientific progress
,
3
(2), 782-789.
20.
Halimova, Y. S. (2023). Morphological Aspects of Rat Ovaries When Exposed to
Caffeine Containing Drink.
BEST JOURNAL OF INNOVATION IN SCIENCE,
RESEARCH AND DEVELOPMENT
,
2
(6), 294-300.
21.
Halimova, Y. S., Shokirov, B. S., & Khasanova, D. A. (2023). Reproduction and
Viability of Female Rat Offspring When Exposed To Ethanol.
Procedia of Engineering
and Medical Sciences
, 32-35.
22.
Salokhiddinovna, H. Y. (2023). Morphological Features of the Human Body in Energy
Drink Abuse.
EUROPEAN
JOURNAL OF INNOVATION IN NONFORMAL
EDUCATION
,
3
(5), 51-53.
23.
Халимова, Ю. С., & Шокиров, Б. С. (2022). СОВРЕМЕННЫЕ ДАННЫЕ О
МОРФО-ФУНКЦИОНАЛЬНЫХ АСПЕКТОВ ЧЕЛОВЕЧЕСКОГО ОРГАНИЗМА
ПРИ ЗЛОУПОТРЕБЛЕНИЕ ЭНЕРГЕТИЧЕСКИМИ НАПИТКАМИ.
PEDAGOGS
jurnali
,
4
(1), 154-161.
24.
Halimova, Y. S. (2023). Morphofunctional Aspects of Internal Organs in Chronic
Alcoholism.
AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI
,
2
(5), 83-87.
25.
Shokirov, B. S. (2021). Halimova Yu. S. Antibiotic-induced rat gut microbiota dysbiosis
and salmonella resistance Society and innovations.
26.
Халимова, Ю. С., & Шокиров, Б. С. (2021). Репродуктивность и жизнеспособность
потомства самок крыс при различной длительности воздействия этанола.
In
Актуальные вопросы современной медицинской науки и здравоохранения:
Материалы VI Международной научно-практической конференции молодых
учёных и студентов, посвященной году науки и технологий,(Екатеринбург, 8-9
апреля 2021): в 3-х т.
. Федеральное государственное бюджетное образовательное
учреждение высшего образования «Уральский государственный медицинский
университет» Министерства здравоохранения Российской Федерации.
27.
Khalimova, Y. S. BS Shokirov Morphological changes of internal organs in chronic
alcoholism.
Middle European scientific bulletin
, 12-2021.
1099
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
28.
Шокиров, Б. С., & Халимова, Ю. С. (2022). ДИСБИОЗ ВЫЗВАННЫЙ
АНИБИОТИКАМИ КИШЕЧНОЙ МИКРОБИОТЫ КРЫС И УСТОЙЧИВОСТЬ К
САЛМОНЕЛЛАМ.
Scientific progress
,
3
(2), 766-772.
29.
Salokhiddinovna, X. Y. (2023). Clinical Features of the Course of Vitamin D Deficiency
in Women of Reproductive Age.
EUROPEAN JOURNAL OF INNOVATION IN
NONFORMAL EDUCATION
,
3
(11), 28-31.
30.
Шокиров, Б., & Халимова, Ю. (2021). Антибиотик-индуцированный дисбиоз
микробиоты кишечника крыс и резистентность к сальмонеллам.
Общество и
инновации
,
2
(4/S), 93-100.
31.
Salokhiddinovna,
X.
Y.
(2023).
MORPHOLOGICAL
CHANGES
IN
PATHOLOGICAL FORMS OF ERYTHROCYTES.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
3
(11), 20-24.
32.
Saloxiddinovna, X. Y. (2023). ERITROTSITLAR PATOLOGIK SHAKLLARINING
MORFOLOGIK O'ZGARISHLARI.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
33
(1), 167-172.
33.
Шокиров, Б., & Халимова, Ю. (2021). Antibiotic-induced rat gut microbiota dysbiosis
and salmonella resistance.
Общество и инновации
,
2
(4/S), 93-100.
34.
Шокиров, Б. С., & Халимова, Ю. С. (2021). Пищеварительная функция кишечника
после коррекции экспериментального дисбактериоза у крыс бифидобактериями.
In
Актуальные вопросы современной медицинской науки и здравоохранения:
Материалы VI Международной научно-практической конференции молодых
учёных и студентов, посвященной году науки и технологий,(Екатеринбург, 8-9
апреля 2021): в 3-х т.
. Федеральное государственное бюджетное образовательное
учреждение высшего образования «Уральский государственный медицинский
университет» Министерства здравоохранения Российской Федерации.
35.
Salokhiddinovna, X. Y. (2023). Anemia of Chronic Diseases.
Research Journal of
Trauma and Disability Studies
,
2
(12), 364-372.
36.
Salokhiddinovna, X. Y. (2023). MALLORY WEISS SYNDROME IN DIFFUSE
LIVER LESIONS.
Journal of Science in Medicine and Life
,
1
(4), 11-15.
37.
Salohiddinovna, X. Y. (2023). SURUNKALI KASALLIKLARDA UCHRAYDIGAN
ANEMIYALAR MORFO-FUNKSIONAL XUSUSIYATLARI.
Ta'lim innovatsiyasi va
integratsiyasi
,
10
(3), 180-188.
38.
Халимова, Ю. С. (2024). КЛИНИКО-МОРФОЛОГИЧЕСКИЕ ОСОБЕННОСТИ
ВИТАМИНА
D
В
ФОРМИРОВАНИЕ
ПРОТИВОИНФЕКЦИОННОГО
1100
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
ИММУНИТА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
36
(3), 86-94.
39.
Saloxiddinovna, X. Y. (2024). CLINICAL FEATURES OF VITAMIN D EFFECTS ON
BONE METABOLISM.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
36
(5), 90-99.
40.
Saloxiddinovna, X. Y. (2024). CLINICAL AND MORPHOLOGICAL ASPECTS OF
AUTOIMMUNE THYROIDITIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
36
(5), 100-108.
41.
Saloxiddinovna, X. Y. (2024). MORPHOFUNCTIONAL FEATURES BLOOD
MORPHOLOGY IN AGE-RELATED CHANGES.
Лучшие интеллектуальные
исследования
,
14
(4), 146-158.
42.
Saloxiddinovna, X. Y. (2024). CLINICAL MORPHOLOGICAL CRITERIA OF
LEUKOCYTES.
Лучшие интеллектуальные исследования
,
14
(4), 159-167.
43.
Saloxiddinovna, X. Y. (2024). Current Views of Vitamin D Metabolism in the
Body.
Best Journal of Innovation in Science, Research and Development
,
3
(3), 235-243.
44.
Saloxiddinovna, X. Y. (2024). MORPHOFUNCTIONAL FEATURES OF THE
STRUCTURE AND DEVELOPMENT OF THE OVARIES.
EUROPEAN JOURNAL
OF MODERN MEDICINE AND PRACTICE
,
4
(4), 220-227.
45.
Saloxiddinovna, X. Y. (2024). Modern Views on the Effects of the Use of
Cholecalciferol on the General Condition of the Bod.
JOURNAL OF HEALTHCARE
AND LIFE-SCIENCE RESEARCH
,
3
(5), 79-85.
46.
Toxirovna, E. G. (2024). QALQONSIMON BEZ KASALLIKLARIDAN HASHIMOTO
TIREODIT KASALLIGINING MORFOFUNKSIONAL O’ZIGA XOSLIGI.
Modern
education and development
,
16
(7), 120-135.
47.
Toxirovna,
E.
G.
(2024).
REVMATOID
ARTRIT:
BO’G'IMLAR
YALLIG'LANISHINING SABABLARI, KLINIK BELGILARI, OQIBATLARI VA
ZAMONAVIY
DAVOLASH
YONDASHUVLARI.
Modern
education
and
development
,
16
(7), 136-148.
48.
Эргашева, Г. Т. (2024). ОЦЕНКА КЛИНИЧЕСКОЙ ЭФФЕКТИВНОСТИ
ОРЛИСТАТА
У
БОЛЬНЫХ
ОЖИРЕНИЕМ
И
АРТЕРИАЛЬНОЙ
ГИПЕРТЕНЗИЕЙ.
Modern education and development
,
16
(7), 92-105.
49.
Ergasheva, G. T. (2024). THE SPECIFICITY OFAUTOIMMUNE THYROIDITIS IN
PREGNANCY.
European Journal of Modern Medicine and Practice
,
4
(11), 448-453.
1101
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 4
50.
Эргашева, Г. Т. (2024). ИССЛЕДОВАНИЕ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ
ПРИ ТИРЕОИДИТЕ ХАШИМОТО.
Modern education and development
,
16
(7), 106-
119.
51.
Toxirovna, E. G. (2024). GIPOFIZ ADENOMASINI NAZORAT QILISHDA
KONSERVATIV JARROHLIK VA RADIATSIYA TERAPIYASINING UZOQ
MUDDATLI SAMARADORLIGI.
Modern education and development
,
16
(7), 79-91.
52.
ERGASHEVA,
G.
T.
(2024).
OBESITY
AND
OVARIAN
INSUFFICIENCY.
Valeology: International Journal of Medical Anthropology and
Bioethics
,
2
(09), 106-111.
53.
Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune
Thyroiditis.
American Journal of Bioscience and Clinical Integrity
,
1
(10), 43-50.
54.
Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN
PATIENTS WITH TYPE 2 DIABETES.
TADQIQOTLAR. UZ
,
40
(3), 55-62.
55.
Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN
PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID
DISEASES.
TADQIQOTLAR. UZ
,
40
(3), 71-77.
56.
Abdurashitovich, Z. F. (2024). ANATOMICAL COMPLEXITIES OF JOINT BONES
OF THE HAND.
EUROPEAN JOURNAL OF MODERN MEDICINE AND
PRACTICE
,
4
(4), 198-206.
57.
Зикриллаев, Ф. А. (2024). АНАТОМИЧЕСКОЕ СТРОЕНИЕ ОРГАНОВ ДЫХАНИЯ
И ЕГО ЛИЧНЫЕ ХАРАКТЕРИСТИКИ.
TADQIQOTLAR. UZ
,
40
(3), 86-93.
58.
Abdurashitovich, Z. F., & Komoliddinovich, S. J. (2024). DIGESTIVE SYSTEM.
ANATOMY OF THE STOMACH.
TADQIQOTLAR. UZ
,
40
(3), 78-85.
59.
Abdurashitovich,
Z.
F.
(2024).
UMURTQA
POG’ONASI
BIRLASHUVLARI.
TADQIQOTLAR. UZ
,
40
(3), 40-47.
60.
Rakhmatova, D. B., & Zikrillaev, F. A. (2022). DETERMINE THE VALUE OF RISK
FACTORS FOR MYOCARDIAL INFARCTION.
FAN, TA'LIM, MADANIYAT VA
INNOVATSIYA JURNALI| JOURNAL OF SCIENCE, EDUCATION, CULTURE AND
INNOVATION
,
1
(4), 23-28.
61.
Abdurashitovich,
Z.
F.
(2024).
MIOKARD
INFARKTI
UCHUN
XAVF
OMILLARINING
AHAMIYATINI
ANIQLASH.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
36
(5), 83-89.
62.
Abdurashitovich, Z. F. (2024). THE RELATIONSHIP OF STRESS FACTORS AND
THYMUS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
36
(6),
188-196.
